In other words, those that existed after march 23, 2010. grandfathered plans in place before that date are exempt from the ac requirements for preventative requirements. all of the tests add up to half a billion dollars each year in revenue for myriad genetics. the company's stock jumped up to a three-year high after jolie's editorial on tuesday. that's just one company profiting from two genes. in the decade since the gee gnome project -- more than 4,000 have been snatched up and pat t patent patented. 20% of the genome. 4,000 tiny pieces of ourselves that are not fully ours. myriad's monopol...